KLRC2 and acute myeloid leukemia: Some of these focus on CMV+ blood superdonors who harbor large preexisting memory-like single KIR+NKG2C+ NK cell subsets that exhibit efficient cytotoxicity against HLA class I-mismatched AML [183].